Neuland Laboratories · NSE: NEULANDLAB · BSE: 524558
Q1 FY24 results · Apr–Jun 2023
Neuland Laboratories reported revenue from operations of ₹362.99 crore (up 64.1% from Q1 FY23) and net profit of ₹61.88 crore (up 520.9% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 362.99 | 221.17 | +64.1% | 407.07 | −10.8% |
| Other income | 2.04 | 0.51 | +298.4% | 8.06 | −74.7% |
| Total income | 365.03 | 221.68 | +64.7% | 415.14 | −12.1% |
| Profit before tax | 83.16 | 13.46 | +517.9% | 110.16 | −24.5% |
| Net profit for the period | 61.88 | 9.97 | +520.9% | 84.54 | −26.8% |
| EPS, basic (₹) | 48.23 | 7.77 | +520.7% | 65.90 | −26.8% |
| Net margin (%) | 17.0 | 4.5 | 20.8 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 362.99 | 221.17 | +64.1% | 407.07 | −10.8% |
| Other income | 2.04 | 0.51 | +298.4% | 8.06 | −74.7% |
| Total income | 365.03 | 221.68 | +64.7% | 415.14 | −12.1% |
| Profit before tax | 83.50 | 13.33 | +526.3% | 110.02 | −24.1% |
| Net profit for the period | 62.22 | 9.84 | +532.3% | 84.51 | −26.4% |
| EPS, basic (₹) | 48.50 | 7.67 | +532.3% | 65.87 | −26.4% |
| Net margin (%) | 17.1 | 4.4 | 20.8 |
Consolidated
- Filed with BSE
- 03 Aug 2023, 16:53 IST
- Board meeting
- 03 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Aug 2023, 16:53 IST
- Board meeting
- 03 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE